Status:
COMPLETED
A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty
Lead Sponsor:
Daiichi Sankyo Co., Ltd.
Conditions:
Venous Thromboembolism
Thromboembolism
Eligibility:
All Genders
20-84 years
Phase:
PHASE2
Brief Summary
The objective of this study is to compare the efficacy, safety of DU-176b 30mg or DU-176b 15mg versus enoxaparin sodium for the prevention of venous thromboembolism in patients after elective total hi...
Eligibility Criteria
Inclusion
- Patients undergoing unilateral total hip arthroplasty
- Patients who are 20-84 years olds
Exclusion
- Subjects with risks of hemorrhage
- Subjects with thromboembolic risks
- Subjects who weigh less than 40 kg
- Subjects who are pregnant or suspect pregnancy, or subjects who want to become pregnant
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
264 Patients enrolled
Trial Details
Trial ID
NCT01203098
Start Date
July 1 2008
End Date
June 1 2009
Last Update
February 25 2019
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Osaka, Japan
2
Tokyo, Japan
3
Kaohsiung City, Taiwan